These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34425215)

  • 1. CG223, a novel BET inhibitor, exerts TGF-β1-mediated antifibrotic effects in a murine model of bleomycin-induced pulmonary fibrosis.
    Kaneshita S; Kida T; Yoshioka M; Nishioka K; Raje M; Sakashita A; Hirano A; Sagawa T; Kasahara A; Inoue T; Fujioka K; Nagahara H; Wada M; Kohno M; Strovel JW; Fletcher S; Ashihara E; Kawahito Y
    Pulm Pharmacol Ther; 2021 Oct; 70():102057. PubMed ID: 34425215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tenofovir alafenamide fumarate attenuates bleomycin-induced pulmonary fibrosis by upregulating the NS5ATP9 and TGF-β1/Smad3 signaling pathway.
    Li L; Zhao J; Zhou L; Chen J; Ma Y; Yu Y; Cheng J
    Respir Res; 2019 Jul; 20(1):163. PubMed ID: 31331325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follistatin-Like 1 Promotes Bleomycin-Induced Pulmonary Fibrosis through the Transforming Growth Factor Beta 1/Mitogen-Activated Protein Kinase Signaling Pathway.
    Jin YK; Li XH; Wang W; Liu J; Zhang W; Fang YS; Zhang ZF; Dai HP; Ning W; Wang C
    Chin Med J (Engl); 2018 Aug; 131(16):1917-1925. PubMed ID: 30082522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P311 Promotes Lung Fibrosis via Stimulation of Transforming Growth Factor-β1, -β2, and -β3 Translation.
    Duan FF; Barron G; Meliton A; Mutlu GM; Dulin NO; Schuger L
    Am J Respir Cell Mol Biol; 2019 Feb; 60(2):221-231. PubMed ID: 30230348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arsenic trioxide inhibits transforming growth factor-β1-induced fibroblast to myofibroblast differentiation in vitro and bleomycin induced lung fibrosis in vivo.
    Luo F; Zhuang Y; Sides MD; Sanchez CG; Shan B; White ES; Lasky JA
    Respir Res; 2014 Apr; 15(1):51. PubMed ID: 24762191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of high-mobility group box 1 and thrombin in murine pulmonary fibrosis and the therapeutic potential of thrombomodulin.
    Kida T; Seno T; Nagahara H; Inoue T; Nakabayashi A; Kukida Y; Fujioka K; Fujii W; Wada M; Kohno M; Kawahito Y
    Am J Physiol Lung Cell Mol Physiol; 2018 Mar; 314(3):L473-L483. PubMed ID: 29212801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baccatin III ameliorates bleomycin-induced pulmonary fibrosis via suppression of TGF-β1 production and TGF-β1-induced fibroblast differentiation.
    Nie Y; Zhang D; Qian F; Wu Y
    Int Immunopharmacol; 2019 Sep; 74():105696. PubMed ID: 31229901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Derrone Targeting the TGF Type 1 Receptor Kinase Improves Bleomycin-Mediated Pulmonary Fibrosis through Inhibition of Smad Signaling Pathway.
    Molagoda IMN; Sanjaya SS; Lee KT; Choi YH; Lee JH; Lee MH; Kang CH; Lee CM; Kim GY
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BET bromodomain proteins mediate downstream signaling events following growth factor stimulation in human lung fibroblasts and are involved in bleomycin-induced pulmonary fibrosis.
    Tang X; Peng R; Ren Y; Apparsundaram S; Deguzman J; Bauer CM; Hoffman AF; Hamilton S; Liang Z; Zeng H; Fuentes ME; Demartino JA; Kitson C; Stevenson CS; Budd DC
    Mol Pharmacol; 2013 Jan; 83(1):283-93. PubMed ID: 23115324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anlotinib attenuated bleomycin-induced pulmonary fibrosis via the TGF-β1 signalling pathway.
    Ruan H; Lv Z; Liu S; Zhang L; Huang K; Gao S; Gan W; Liu X; Zhang S; Helian K; Li X; Zhou H; Yang C
    J Pharm Pharmacol; 2020 Jan; 72(1):44-55. PubMed ID: 31659758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycosyltransferases and glycosaminoglycans in bleomycin and transforming growth factor-β1-induced pulmonary fibrosis.
    Venkatesan N; Tsuchiya K; Kolb M; Farkas L; Bourhim M; Ouzzine M; Ludwig MS
    Am J Respir Cell Mol Biol; 2014 Mar; 50(3):583-94. PubMed ID: 24127863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifibrotic effects of cyclosporine A on TGF-β1-treated lung fibroblasts and lungs from bleomycin-treated mice: role of hypoxia-inducible factor-1α.
    Yamazaki R; Kasuya Y; Fujita T; Umezawa H; Yanagihara M; Nakamura H; Yoshino I; Tatsumi K; Murayama T
    FASEB J; 2017 Aug; 31(8):3359-3371. PubMed ID: 28446589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The novel inhibitor PRI-724 for Wnt/β-catenin/CBP signaling ameliorates bleomycin-induced pulmonary fibrosis in mice.
    Okazaki H; Sato S; Koyama K; Morizumi S; Abe S; Azuma M; Chen Y; Goto H; Aono Y; Ogawa H; Kagawa K; Nishimura H; Kawano H; Toyoda Y; Uehara H; Kouji H; Nishioka Y
    Exp Lung Res; 2019 Sep; 45(7):188-199. PubMed ID: 31298961
    [No Abstract]   [Full Text] [Related]  

  • 14. Paroxetine protects against bleomycin-induced pulmonary fibrosis by blocking GRK2/Smad3 pathway.
    Zhao K; Nie H; Tang Z; Chen G; Huang J
    Aging (Albany NY); 2023 Oct; 15(19):10524-10539. PubMed ID: 37815883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis.
    Oku H; Shimizu T; Kawabata T; Nagira M; Hikita I; Ueyama A; Matsushima S; Torii M; Arimura A
    Eur J Pharmacol; 2008 Aug; 590(1-3):400-8. PubMed ID: 18598692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRIM33 prevents pulmonary fibrosis by impairing TGF-β1 signalling.
    Boutanquoi PM; Burgy O; Beltramo G; Bellaye PS; Dondaine L; Marcion G; Pommerolle L; Vadel A; Spanjaard M; Demidov O; Mailleux A; Crestani B; Kolb M; Garrido C; Goirand F; Bonniaud P
    Eur Respir J; 2020 Jun; 55(6):. PubMed ID: 32184320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrogen inhalation attenuated bleomycin-induced pulmonary fibrosis by inhibiting transforming growth factor-β1 and relevant oxidative stress and epithelial-to-mesenchymal transition.
    Gao L; Jiang D; Geng J; Dong R; Dai H
    Exp Physiol; 2019 Dec; 104(12):1942-1951. PubMed ID: 31535412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A neutrophil elastase inhibitor prevents bleomycin-induced pulmonary fibrosis in mice.
    Takemasa A; Ishii Y; Fukuda T
    Eur Respir J; 2012 Dec; 40(6):1475-82. PubMed ID: 22441751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-fibrotic effect of iguratimod on pulmonary fibrosis by inhibiting the fibroblast-to-myofibroblast transition.
    Lin H; Wu C; Zhu F; Zhang G; Xie Y; Cui Y; Dong G; Zhang X
    Adv Med Sci; 2020 Sep; 65(2):338-347. PubMed ID: 32590154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nagilactone D ameliorates experimental pulmonary fibrosis in vitro and in vivo via modulating TGF-β/Smad signaling pathway.
    Li A; Xiao X; Feng ZL; Chen X; Liu LJ; Lin LG; Lu JJ; Zhang LL
    Toxicol Appl Pharmacol; 2020 Jan; 389():114882. PubMed ID: 31953203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.